Controversies in antibiotic choices for odontogenic infections.
Stefanopoulos
Panagiotis K
PK
Kolokotronis
Alexandros E
AE
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001372:Aza Compounds / Q000494:pharmacology / Q000627:therapeutic use*; D001421:Bacteria, Anaerobic / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy; D002981:Clindamycin / Q000494:pharmacology / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial; D024841:Fluoroquinolones; D005491:Focal Infection, Dental / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D000077266:Moxifloxacin; D011804:Quinolines / Q000494:pharmacology / Q000627:therapeutic use*; D013030:Spain; D013290:Streptococcal Infections / Q000188:drug therapy; D034363:Viridans Streptococci / Q000187:drug effects
D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D002981:Clindamycin; D000077266:Moxifloxacin